Finance

Lists
Why is BALAXI up ८.२९%?
Dive Deeper
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹ २२.२०
+८.२९%
(+१.७०) 1D
नोभेम्बर ५, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹ २०.९०
High
₹ २२.३५
Low
₹ २०.७७
Mkt. cap
१.२१ अरब
Avg. vol.
२३.४७ हजार
Volume
१७.९० हजार
P/E ratio
५०.२१
52-wk high
₹ ४२.९०
52-wk low
₹ १५.२०
EPS
₹ ०.४४
No. of employees
५००
Open
₹ २०.९०
High
₹ २२.३५
Low
₹ २०.७७
Mkt. cap
१.२१ अरब
Avg. vol.
२३.४७ हजार
Volume
१७.९० हजार
P/E ratio
५०.२१
52-wk high
₹ ४२.९०
52-wk low
₹ १५.२०
EPS
₹ ०.४४
No. of employees
५००
News stories
From web sources and news partners
Investing News Network
Investing News Network
·
१७ मिनेट पहिले
NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
The Robot Report
The Robot Report
·
३१ मिनेट पहिले
Agility Robotics begins trading on Nasdaq
Reuters
Reuters
·
४३ मिनेट पहिले
Nasdaq falls at open after midterms-fueled surge as chip, data center stocks fall
CNN
CNN
·
१ दिन पहिले
Dow has best post-midterm elections day in 44 years as Democrats take control of Congress
About Balaxi Pharmaceuticals Ltd
CEO-
Employees५००
Founded१९४२
Headquarters-
Sector-
Industry-
Websitebalaxipharma.in
Last report
२०२६ अगस्ट ५
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
८०.६८ करोड / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५६.१८ करोड
७२.५४ करोड
७०.७१ करोड
८०.६८ करोड
Cost of goods sold
२९.०३ करोड
४१.७४ करोड
४१.४९ करोड
४३.१७ करोड
Cost of revenue
२९.०३ करोड
४१.७४ करोड
४१.४९ करोड
४३.१७ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.९८ करोड
२७.७२ करोड
२९.१० करोड
३२.८५ करोड
Operating expense
२६.४६ करोड
२८.२८ करोड
२९.७५ करोड
३३.६९ करोड
Total operating expenses
५५.४९ करोड
७०.०१ करोड
७१.२४ करोड
७६.८७ करोड
Operating income
६८.४१ लाख
२.५३ करोड
-५२.४९ लाख
३.८१ करोड
Other non operating income
१.५८ करोड
९.५७ लाख
१.८३ करोड
-९९.२२ लाख
EBT including unusual items
१.३८ करोड
१.६१ करोड
१.४० करोड
२.०९ करोड
EBT excluding unusual items
१.३८ करोड
१.६१ करोड
१.३० करोड
२.०९ करोड
Income tax expense
१.१७ करोड
१.३० करोड
७८.९८ लाख
७९.१८ लाख
Effective tax rate
८४.८२%
८१.०५%
५६.३१%
३७.९०%
Other operating expenses
-
-
-
-
Net income
२०.९० लाख
३०.५० लाख
६१.२८ लाख
१.३० करोड
Net profit margin
०.३७%
०.४२%
०.८७%
१.६१%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
-७३.२६ लाख
Net interest expenses
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
-७३.२६ लाख
Depreciation and amortization charges
४८.४५ लाख
५५.९५ लाख
६४.६५ लाख
८४.८५ लाख
EBITDA
१.१६ करोड
२.९६ करोड
-३.२९ लाख
४.३१ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू